Bangkok to Host International Vaccine Manufacturers Conference, QSMI and BioNet to Co-host 16th AGM of DCVMN, on October 5th, 2015

Prof. Sumana Khomvilai, Deputy Director of QSMI said: "On behalf of the DCVMN AGM 2015 Organizing Committee, we are pleased to welcome all delegates to the conference. We hope the meeting will be a unique opportunity to address the challenges related to vaccine production and procurement."

Indeed, world vaccine experts including from the World Health Organization UNICEF, Bill & Melinda Gates Foundation, GAVI, PATH and PAHO will gather to discuss vaccine demand, supply shortage and vaccine security, while a panel of speakers will also present novel technologies to develop new vaccines against infectious diseases such as chikungunya, dengue, pertussis and cholera.

During the opening ceremony, Dr Mahendra Suhardono, President of DCVMN, also emphasized the important role of DCVMs in the global efforts to eradicate poliomyelitis disease by supplying OPV vaccines for immunization programs. He also called for a cooperation spirit and close interaction among WHO, UNICEF, DCVM, and all relevant eradication initiatives in order to contribute to the success of polio eradication in the world.

About DCVMN

DCVMN is an international alliance of manufacturers aiming to protect people against known and emerging infectious diseases globally by increasing the availability and enhancing the quality of vaccines produced in emerging countries. The network includes today 44 vaccine manufacturers, in 16 countries, producing and supplying over 40 different types of vaccines. www.dcvmn.org

About QSMI

The Queen Saovabha Memorial Institute of the Thai Red Cross Society is an institute producing BCG vaccine, equine Rabies Immunoglobulins and snake antivenoms, using the latest technology and equipment. QSMI is also a World Health Organization Collaborating Center for research on Rabies and venomous snakes. www.saovabha.com

About BioNet

BioNet-Asia is a clinical-stage biotech company with a focus on technological innovation and global market access. BioNet is developing recombinant Pertussis and Dengue vaccines. The company has also built up global partnerships, leading to the production of billions of doses of vaccines worldwide. www.bionet-asia.com

For further information, please contact:
Mr. Supachai Nampornchaisakul
BioNet-Asia Co., Ltd.
E-mail: [email protected]
Tel. +66 2361 8110

www.bionet-asia.com

Photo - http://photos.prnewswire.com/prnh/20151005/273773LOGO